[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2016-2020 Future Horizons and Growth Strategies in the EU5 Drugs of Abuse Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

March 2016 | 300 pages | ID: 2569695A8E5EN
Venture Planning Group

US$ 5,200.00 US$ 6,500.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Complete report $6,500. DataPack (test volumes, sales forecasts, supplier shares) $5,500. This new 300-page report from VPGMarketResearch provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene. During the next five years, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. This unique study is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; and provides test volume and sales forecasts, by market segment and individual assay.

Contains 300 pages and 48 tables
COMPETITIVE ASSESSMENTS

Abbott Laboratories
AdnaGen/Alere
Agilent Technologies
Bayer Healthcare
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
BioRad
DiaSorin
Eiken
Fujirebio
Grifols
Instrumentation Laboratory
Kyowa Medex
Matritech/Alere
OrthoClinical Diagnostics
Quest Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Wako
Wallac/PE

LIST OF TABLES

France Sales and Market Shares of Major Suppliers of Clinical Chemistry Diagnostic Products
France Sales and Market Shares of Major Suppliers of Immunodiagnostic Products
Germany Sales and Market Share of Major Suppliers of Clinical Chemistry Diagnostic Products
Germany Sales and Market Shares of Major Suppliers of Immunodiagnostic Products
Italy Sales and Market Shares of Major Suppliers of Clinical Chemistry Diagnostic Products
Italy Sales and Market Shares of Major Suppliers of Immunodiagnostic Product
Spain Sales and Market Shares of Major Suppliers of Clinical Chemistry Diagnostic Products
Spain Sales and Market Shares of Major Suppliers of Immunodiagnostic Product
UK Sales and Market Shares of Major Suppliers of Clinical Chemistry Diagnostic Products
UK Sales and Market Shares of Major Suppliers of Immunodiagnostic Products


More Publications